Triple

T17354635
Position Surface form Disambiguated ID Type / Status
Subject National Toxicology Program E421902 entity
Predicate cooperatingAgency P31845 FINISHED
Object Center for Drug Evaluation and Research NE ONNED1

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Center for Drug Evaluation and Research | Statement: [National Toxicology Program, cooperatingAgency, Center for Drug Evaluation and Research]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Center for Drug Evaluation and Research
Context triple: [National Toxicology Program, cooperatingAgency, Center for Drug Evaluation and Research]
  • A. Center for Drug Evaluation and Research chosen
    The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
  • B. Center for Biologics Evaluation and Research
    The Center for Biologics Evaluation and Research is the U.S. regulatory body responsible for overseeing the safety, efficacy, and quality of biological products such as vaccines, blood products, and gene therapies.
  • C. Office of Generic Drugs
    The Office of Generic Drugs is a division of the U.S. Food and Drug Administration responsible for reviewing and approving generic medications to ensure they are safe, effective, and therapeutically equivalent to brand-name drugs.
  • D. Food and Drug Administration
    The Food and Drug Administration is a U.S. federal agency responsible for protecting public health by regulating food, drugs, medical devices, and other consumer products.
  • E. Center for Devices and Radiological Health
    The Center for Devices and Radiological Health is the U.S. FDA division responsible for regulating medical devices and radiation-emitting products to ensure their safety and effectiveness.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d889d520008190a26917a95bf1c2ea completed April 10, 2026, 5:25 a.m.
NER Named-entity recognition batch_69e43a2f26548190a8822b2470ec3c72 completed April 19, 2026, 2:13 a.m.
NED1 Entity disambiguation (via context triple) batch_6a01955a50dc819090c1a0ec111d9fc0 in_progress May 11, 2026, 8:37 a.m.
Created at: April 10, 2026, 5:44 a.m.